![Kevin George Bilyard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin George Bilyard
Corporate Officer/Principal presso Gardant Pharmaceuticals, Inc.
Profilo
Kevin George Bilyard is currently a Senior Vice President at Gardant Pharmaceuticals, Inc. He previously worked as a Non-Executive Director at Accura Animal Health Plc and as a Member-Management Board at Quadrant Healthcare Plc.
Dr. Bilyard earned a doctorate degree from the University of London in 1981.
Posizioni attive di Kevin George Bilyard
Società | Posizione | Inizio |
---|---|---|
Gardant Pharmaceuticals, Inc.
![]() Gardant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gardant Pharmaceuticals, Inc. develops and commercializes pharmaceutical compounds. It develops network for research, clinical development, and project management and guides them through the clinical development and licensing stages. The company was founded in 2000 and is headquartered in New York, NY | Corporate Officer/Principal | - |
Precedenti posizioni note di Kevin George Bilyard
Società | Posizione | Fine |
---|---|---|
Accura Animal Health Plc
![]() Accura Animal Health Plc Pharmaceuticals: MajorHealth Technology Accura Animal Health Plc is a pharmaceutical and diagnostic company. It focuses on the animal health market. The company operations are divided into two divisions: Animal Health Pharmaceuticals and Animal Health Diagnostics. The Animal Health Pharmaceuticals is focused on the development, manufacture and commercialization of pharmaceuticals to improving the quality of life and maintaining the health of companion animals. The Animal Health Diagnostics manufactures and sells acute phase protein diagnostic products for animal health and welfare screening. The company was founded in 2006 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 14/12/2010 |
Quadrant Healthcare Plc
![]() Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Corporate Officer/Principal | - |
Formazione di Kevin George Bilyard
University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Gardant Pharmaceuticals, Inc.
![]() Gardant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gardant Pharmaceuticals, Inc. develops and commercializes pharmaceutical compounds. It develops network for research, clinical development, and project management and guides them through the clinical development and licensing stages. The company was founded in 2000 and is headquartered in New York, NY | Health Technology |
Accura Animal Health Plc
![]() Accura Animal Health Plc Pharmaceuticals: MajorHealth Technology Accura Animal Health Plc is a pharmaceutical and diagnostic company. It focuses on the animal health market. The company operations are divided into two divisions: Animal Health Pharmaceuticals and Animal Health Diagnostics. The Animal Health Pharmaceuticals is focused on the development, manufacture and commercialization of pharmaceuticals to improving the quality of life and maintaining the health of companion animals. The Animal Health Diagnostics manufactures and sells acute phase protein diagnostic products for animal health and welfare screening. The company was founded in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
Quadrant Healthcare Plc
![]() Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Health Technology |
- Borsa valori
- Insiders
- Kevin George Bilyard